PHARMACEUTICAL ANNUAL PRODUCT REVIEW (APR) CHECKLIST

Created by ChecklistGuro (https://checklistguro.com)


--- COMMERCIAL DATA REVIEW ---
[ ] Total Sales Revenue (USD)
[ ] Units Sold
[ ] Market Share (%)
[ ] Primary Market Segment (Hospital, Pharmacy, Direct to Patient, Wholesale)
[ ] Last Sales Data Update Date
[ ] Summary of Market Trends

--- QUALITY PERFORMANCE EVALUATION ---
[ ] Total Number of Deviations
[ ] Number of CAPAs Opened
[ ] Number of Customer Complaints Received
[ ] Overall Quality System Rating (e.g., Excellent, Good, Needs Improvement) (Excellent, Good, Needs Improvement, Unsatisfactory)
[ ] Last Internal Audit Date
[ ] Summary of Significant Quality Trends
[ ] Were there any critical deviations? (Yes/No) (Yes, No)
[ ] Supporting Documentation (e.g., Deviation Reports, Audit Findings)

--- STABILITY DATA ANALYSIS ---
[ ] Review Date
[ ] Batch Number
[ ] Temperature (°C)
[ ] Humidity (%)
[ ] Stability Protocol Followed (ICH Q1A, Company Specific, Other)
[ ] Visual Inspection Results (Scale 1-5, 1=Excellent, 5=Unacceptable)
[ ] Detailed Observations & Comments
[ ] Attached Stability Data Reports

--- MANUFACTURING PROCESS REVIEW ---
[ ] Overall Yield (%)
[ ] Process Efficiency (%)
[ ] Description of any Process Deviations
[ ] Equipment Performance Rating (Excellent, Good, Fair, Poor) (Excellent, Good, Fair, Poor)
[ ] Date of Last Equipment Maintenance
[ ] Attachment: Process Validation Report (if applicable)
[ ] Summary of Improvements Implemented This Year

--- REGULATORY COMPLIANCE UPDATE ---
[ ] Last Regulatory Inspection Date
[ ] Applicable Regulatory Frameworks (e.g., cGMP, EU GMP) (cGMP (US FDA), EU GMP, ICH Guidelines, Other (Specify in LONG_TEXT))
[ ] Summary of Regulatory Updates (new guidelines, interpretations)
[ ] Number of Significant Regulatory Changes Identified
[ ] Status of Outstanding Regulatory Actions (if any) (Open, Closed, In Progress)
[ ] Supporting Documentation (e.g., inspection reports, regulatory correspondence)

--- PRODUCT LABELING AND PACKAGING REVIEW ---
[ ] Labeling Revision Status (Original, Revised, Pending Revision)
[ ] Primary Label Revision Date
[ ] Labeling Change Justification
[ ] Current Primary Label Image
[ ] Packaging Material Compliance (Compliant, Non-Compliant, Pending Assessment)
[ ] Tamper-Evident Features Verification (Quantity)
[ ] Packaging Defects Observed (if any)
[ ] Next Labeling Review Date

--- RISK ASSESSMENT & MITIGATION ---
[ ] Identify Potential Risks
[ ] Risk Priority Score (1-10)
[ ] Risk Category (e.g., Quality, Manufacturing, Regulatory) (Quality, Manufacturing, Regulatory, Supply Chain, Commercial)
[ ] Existing Mitigation Strategies
[ ] Severity Assessment (Select all that apply) (Minor, Moderate, Major, Critical)
[ ] Proposed Additional Mitigation Actions (if needed)
[ ] Implementation Date of New Mitigation Actions
[ ] Reviewer Signature

--- POST-MARKET SURVEILLANCE DATA ---
[ ] Number of Adverse Event Reports Received
[ ] Summary of Significant Adverse Event Trends
[ ] Review of Periodic Safety Update Reports (PSURs) (Completed & Reviewed, In Progress, Not Applicable)
[ ] Supporting Documentation (e.g., Trend Analysis Reports)
[ ] Date of Last PSUR Submission
[ ] Signal Detection Activities Performed (Literature Review, Database Analysis, Spontaneous Reporting Analysis, Automated Signal Detection)

--- LIFECYCLE MANAGEMENT CONSIDERATIONS ---
[ ] Potential Product Enhancements (Formulation, Dosage Form)
[ ] Potential Line Extensions (New Indications, Patient Populations) (New Therapeutic Indication, Expanded Patient Population, Combination Product, Pediatric Formulation)
[ ] Estimated Market Size for Line Extension (Units/Year)
[ ] Target Date for Line Extension Launch (if applicable)
[ ] Potential Product Discontinuation (if applicable) (No Discontinuation Planned, Discontinuation Considered)
[ ] Justification for Discontinuation (if applicable)
[ ] Impact Assessment (if product discontinued) (Minimal Impact, Moderate Impact, Significant Impact)

--- SUMMARY AND RECOMMENDATIONS ---
[ ] Overall Summary of APR Findings
[ ] Proposed Budget Increase/Decrease (%)
[ ] Date of Next Review
[ ] Recommended Actions (select all that apply) (Process Optimization, Stability Testing Expansion, Labeling Update, Regulatory Consultation, Further Investigation)
[ ] Responsible Party for Action Implementation
[ ] Reviewer Signature

--- END OF TEMPLATE ---
Transform this text into a digital, automated, and trackable mobile app!
Visit: https://checklistguro.com/templates/pharmaceutical/pharmaceutical-annual-product-review-apr-checklist
(Click "Install Template" to launch your digital inspection tool immediately)